Pre-treatment characteristics and long-term outcomes of recurrent-metastatic head and neck cancer patients treated with immune checkpoint inhibitors

被引：1
|
作者：
Issa, M. [1 ]
Schultz, T. [1 ]
Xu, M. [1 ]
Bhateja, P. [1 ]
Karivedu, V. [1 ]
Dibs, K. [2 ]
Old, M. [3 ]
Kang, S. [3 ]
Gamez, M. [2 ]
Grecula, J. [2 ]
Jhawar, S. [2 ]
Mitchell, D. [2 ]
Seim, N. [3 ]
Agrawal, A. [3 ]
Ozer, E. [3 ]
Baliga, S. S. B. E. [2 ]
Carrau, R. [3 ]
Rocco, J. [3 ]
Blakaj, D. [2 ]
Bonomi, M. [1 ]
机构：
[1] Ohio State Univ, Comprehens Canc Ctr James, Med Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, Comprehens Canc Ctr James, OSUCCC, Radiat Oncol Dept, Columbus, OH 43210 USA
[3] Ohio State Univ, James Canc Hosp, Otolaryngol, Columbus, OH 43210 USA
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1063
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
948P
引用
收藏
页码：S674 / S675
页数：2
相关论文
共 50 条
  • [31] Relationship between immune-related adverse events and the long-term outcomes in recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab
    Matsuo, Mioko
    Yasumatsu, Ryuji
    Masuda, Muneyuki
    Toh, Satoshi
    Wakasaki, Takahiro
    Hashimoto, Kazuki
    Taura, Masahiko
    Uchi, Ryutaro
    Nakagawa, Takashi
    ORAL ONCOLOGY, 2020, 101
  • [32] Pre-treatment psychoeducational intervention and outcomes in head and neck cancer patients undergoing radiotherapy
    Malik, Nauman H.
    Maganti, Manjula
    McQuestion, Maurene
    Tjong, Michael C.
    Keilty, Dana
    Monteiro, Eric
    Huang, Shao Hui
    Jang, Raymond Woo-Jun
    Gomes, Andrea
    Pun, Joanne
    Ringash, Jolie
    SUPPORTIVE CARE IN CANCER, 2021, 29 (03) : 1643 - 1652
  • [33] Pre-treatment psychoeducational intervention and outcomes in head and neck cancer patients undergoing radiotherapy
    Nauman H. Malik
    Manjula Maganti
    Maurene McQuestion
    Michael C. Tjong
    Dana Keilty
    Eric Monteiro
    Shao Hui Huang
    Raymond Woo-Jun Jang
    Andrea Gomes
    Joanne Pun
    Jolie Ringash
    Supportive Care in Cancer, 2021, 29 : 1643 - 1652
  • [34] Pre-treatment Class Attendance and Outcomes in Head & Neck Cancer Patients Undergoing Radiation
    Malik, N.
    Maganti, M.
    McQuestion, M.
    Tjong, M. C.
    Keilty, D.
    Monteiro, E.
    Huang, S.
    Jang, R.
    Gomes, A.
    Pun, J.
    Ringash, J. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E378 - E378
  • [35] Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitors
    Rogiers, Anne
    Boekhout, Annelies
    Schwarze, Julia K.
    Awada, Gil
    Blank, Christian U.
    Neyns, Bart
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [36] Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients
    Chalker, Cameron
    Voutsinas, Jenna M.
    Wu, Qian Vicky
    Santana-Davila, Rafael
    Hwang, Victoria
    Baik, Christina S.
    Lee, Sylvia
    Barber, Brittany
    Futran, Neal D.
    Houlton, Jeffrey J.
    Laramore, George E.
    Liao, Jay Justin
    Parvathaneni, Upendra
    Martins, Renato G.
    Eaton, Keith D.
    Rodriguez, Cristina P.
    CANCER MEDICINE, 2022, 11 (22): : 4104 - 4111
  • [37] Immunomethylomic profiles of long-term head and neck squamous cell carcinoma survivors on immune checkpoint inhibitors
    Lee, Min Kyung
    Zhang, Ze
    Sehgal, Kartik
    Butler, Rondi
    Stolrow, Hannah
    Ramush, Geat
    Shirai, Keisuke
    Koestler, Devin C.
    Salas, Lucas A.
    Wiencke, John K.
    Haddad, Robert
    Kelsey, Karl T.
    Christensen, Brock C.
    EPIGENOMICS, 2024, 16 (11-12) : 799 - 807
  • [38] Pre-treatment dysphagia in head-and-neck cancer patients
    Lehner, Uta
    Zaretsky, Eugen
    Goeze, Almut
    Wermter, Laura
    Stuck, Boris A.
    Birk, Richard
    Neff, Andreas
    Fischer, Ingo
    Ghanaati, Shahram
    Sader, Robert
    Hey, Christiane
    HNO, 2022, 70 (07) : 533 - 539
  • [39] Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitors
    Maillet, Denis
    Corbaux, Pauline
    Stelmes, Jean-Jacques
    Dalle, Stephane
    Locatelli-Sanchez, Myriam
    Perier-Muzet, Marie
    Duruisseaux, Michael
    Kiakouama-Maleka, Lize
    Freyer, Gilles
    Boespflug, Amlie
    Peron, Julien
    EUROPEAN JOURNAL OF CANCER, 2020, 132 : 61 - 70
  • [40] The predictive and prognostic value of weight loss and body composition prior to and during treatment with immune checkpoint inhibitors in patients with recurrent or metastatic head and neck cancer.
    Willemsen, Anna C. H.
    De Moor, Nina
    Van Dessel, Jeroen
    Bila, Michel
    Baijens, Laura W. J.
    Hauben, Esther
    Van Den Hout, Mari
    Hoeben, Ann
    Clement, Paul M.
    Schols, Annemie M. W. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18027 - E18027
12345